SCHEMBL28290676

SCHEMBL28290676

NC(=O)c1cccc(-c2ccc([N+](=O)[O-])cc2Cl)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 3/20 0.61
▸ KMT2A Q03164 2/20 0.55
▸ ALDH1A1 P00352 3/20 0.47
▸ ERN1 O75460 1/20 0.45
▸ CES2 O00748 1/20 0.45
▸ CES1 P23141 1/20 0.45
▸ HSD17B10 Q99714 1/20 0.45
▸ PRSS1 P07477 1/20 0.44
▸ PRSS2 P07478 1/20 0.44
▸ PRSS3 P35030 1/20 0.44
▸ TP53 P04637 1/20 0.44
▸ LMNA P02545 1/20 0.44
▸ GAA P10253 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ PARP1 P09874 1/20 0.44
▸ MAPT P10636 1/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ ASH1L Q9NR48 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28245589 0.81 TSHR (0.81) TSHRKMT2AALDH1A1ERN1CES2
SCHEMBL3725488 0.80 TSHR (0.68) TSHRERN1CES2CES1PRSS1
SCHEMBL29018355 0.78 KMT2A (0.67) TSHRKMT2AALDH1A1HSD17B10LMNA
SCHEMBL3019503 0.78 HSD17B10 (0.58) KMT2AALDH1A1CES1HSD17B10MAPT
SCHEMBL894417 0.77 TSHR (1.00) TSHRKMT2AALDH1A1CES2CES1
SCHEMBL29848105 0.77 TSHR (1.00) TSHRKMT2AALDH1A1CES2CES1
SCHEMBL28012071 0.77 KMT2A (0.61) TSHRKMT2AALDH1A1HSD17B10TP53
Hydrochloric Acid SCHEMBL7389430 0.76 TSHR (0.96) TSHRKMT2AALDH1A1CES2CES1
Methane SCHEMBL28159024 0.76 TSHR (0.96) TSHRKMT2AALDH1A1CES2CES1
SCHEMBL27872956 0.75 ERN1 (0.48) TSHRALDH1A1ERN1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109562137-A Methods and compositions for treating conditions associated with abnormal inflammatory responses 第波生物公司 2019-04-02 — — CN disclosed
Send feedback